Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Cash from Investing Activities
Mayinglong Pharmaceutical Group Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Cash from Investing Activities
-¥102.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-22%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Cash from Investing Activities
-¥242m
|
CAGR 3-Years
52%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Investing Activities
-¥5.9B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Investing Activities
¥73.3m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Investing Activities
¥518.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-102.6m
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Cash from Investing Activities amounts to -102.6m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-22%
Over the last year, the Cash from Investing Activities growth was 62%.